Rezpira Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage Patient Counseling Information MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Per 25 mcg/250 mcg/actuation MDI Salmeterol xinafoate 25 mcg, fluticasone propionate 250 mcg

Indications/Uses

Regular treatment of asthma, where use of a combination product (long-acting β2 agonist & inhaled corticosteroid) is appropriate. Patients not adequately controlled w/ inhaled corticosteroids & as needed inhaled short acting β2 agonist; already adequately controlled on both inhaled corticosteroid & long-acting β2 agonist.

Click to view Rezpira detailed prescribing information

Dosage/Direction for Use

Adult including elderly & adolescent >12 yr 2 puffs bid.

Click to view Rezpira detailed prescribing information

Overdosage

View Rezpira overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity.

Click to view Rezpira detailed prescribing information

Warnings

For additional cautionary notes to warn of the potential risk of using the medicine... Click to view Rezpira detailed prescribing information

Special Precautions

Do not use to treat acute asthma symptoms for which fast & short-acting bronchodilator is required. Do not stop treatment abruptly. Patients w/ active or quiescent pulmonary TB & severe thyrotoxicosis. Pregnancy & lactation. May reduce growth velocity in childn.

Click to view Rezpira detailed prescribing information

Use In Pregnancy & Lactation

Click to view Rezpira detailed prescribing information

Adverse Reactions

Salmeterol xinafoate: Tremor, subjective palpitations & headache. Cardiac arrhythmias; Cushing's syndrome, Cushingoid features, adrenal suppression, decrease in bone mineral density, cataract & glaucoma. Fluticasone propionate: Hoarseness & candidiasis (thrush) of the mouth & throat.

Click to view Rezpira detailed prescribing information

Storage

View Rezpira storage conditions for details to ensure optimal shelf-life.

Description

View Rezpira description for details of the chemical structure and excipients (inactive components).

Action

View Rezpira mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antiasthmatic & COPD Preparations

ATC Classification

R03AK06 - salmeterol and fluticasone ; Belongs to the class of adrenergics in combination with corticosteroids or other drugs, excluding anticholinergics. Used in the treatment of obstructive airway diseases.

Regulatory Classification

Patient Counseling Information

View Rezpira patient counselling information

Presentation/Packing

Form

Rezpira 25 mcg/250 mcg/actuation MDI

Packing/Price

120 actuation x 1's (P600/box)

Rezpira

salmeterol + fluticasone

Manufacturer:

ACME

Distributor:

Bell-Kenz Pharma

Marketer:

Euro Generics